CAROL SCHAFER
CIK 1272181 · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.52M
Companies
7
Total Filings
41
Lifetime Open-Market Net
$176.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KURA | Director | — | $9.05 | — | $0 | 7 | 2026-06-04 |
| INSM | Director | 66,622 | $97.85 | $6.52M | $0 | 8 | 2026-05-15 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | 0 | $2.65 | $0 | $160.0K | 6 | 2026-01-28 |
| IMNM | Director | — | $18.38 | — | $0 | 3 | 2025-06-12 |
| Aceragen, Inc. (IDRA) Delisted | Director | 59,665 | $7.22 | $431.1K | $16.7K | 13 | 2022-06-27 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | — | $38.00 | — | $0 | 2 | 2021-04-19 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | — | $178.75 | — | $0 | 2 | 2019-06-12 |
Recent Filings · Page 3 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-04 | KURA | Grant (A) | — | $0 | EDGAR |
| 2021-05-14 | INSM | Grant (A) | +7,558 | $0 | EDGAR |
| 2021-05-14 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-19 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2021-04-05 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | +11,177 | $14.8K | EDGAR |
| 2021-01-06 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | +3,620 | $14.6K | EDGAR |
| 2020-10-05 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | +6,111 | $13.7K | EDGAR |
| 2020-07-02 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | +7,681 | $13.7K | EDGAR |
| 2020-06-25 | Repare Therapeutics Inc. (RPTX) Delisted | Buy (P) | +8,000 | $160.0K | EDGAR |
| 2020-05-19 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.